LOADINGLoading your Pro surface...
Vitamin E has anticoagulant properties at >400 IU; increased bleeding risk
Additive antiplatelet effects
Vitamin E may reduce HDL-raising effect of niacin combination therapy
Antioxidant may protect cancer cells from oxidative treatment
May alter cyclosporine metabolism
A 2005 meta-analysis of 135,967 participants found high-dose vitamin E (≥400 IU/day) was associated with increased all-cause mortality (RR 1.04, 95% CI 1.01-1.07) (PMID: 15537682). The effect was dose-dependent. This analysis changed clinical practice and led to recommendations against routine high-dose vitamin E supplementation.
Not Prohibited
Sanyal AJ et al. Pioglitazone, vitamin E, or placebo for NASH (PIVENS trial).
Dysken MW et al. Effect of vitamin E and memantine on functional decline in Alzheimer disease (TEAM-AD trial).
Miller ER et al. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality.
Lippman SM et al. Effect of selenium and vitamin E on risk of prostate cancer (SELECT trial).
Independently graded against 173,636 indexed supplements with 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, and NIH DSLD | Last updated: April 2026
Not medical advice. Based on published clinical research and systematic reviews.
Vitamin E · interaction landscape
5 flagged
0
Dangerous
4
Moderate
0
Timing
1
Pre-op
Safety
Moderate interactions. Monitoring, timing separation, or dose adjustment may be required.
Warfarin and other anticoagulants
SourceClinical pharmacology
Aspirin and NSAIDs
SourceClinical consensus
Chemotherapy (alkylating agents)
SourceTheoretical, debated
Statins combined with niacin
SourceLimited evidence
Stop 2 weeks before surgery
High-dose bleeding risk.
Educational information only. This is not medical advice. These statements have not been evaluated by the FDA. Talk to your prescriber before starting, stopping, or combining any supplement with prescription medication.